Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia

Nanotoxicology

Volumn 8, Issue 2, 2014, Pages 158-168

  Bertero, Alice ^a   Boni, Adriano ^a   Gemmi, Mauro ^a   Gagliardi, Mariacristina ^a   Bifone, Angelo ^a   Bardi, Giuseppe ^a  

^a CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

Author keywords

Endothelial cells; Glia; in vitro; Neuroinflammation; Polymer functionalisation

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; DENDRIMER; LACTATE DEHYDROGENASE; POLYAMIDOAMINE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; CELL MEMBRANE; CONFOCAL MICROSCOPY; ELECTRON ENERGY LOSS SPECTROSCOPY; ENDOTHELIUM CELL; ENZYME RELEASE; FLOW CYTOMETRY; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY;

AMINES; ANIMALS; BLOOD-BRAIN BARRIER; CELL LINE; CELL SURVIVAL; DENDRIMERS; ENDOTHELIAL CELLS; LIPIDS; MICE; MICROGLIA;

EID: 84883469004     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.765054     Document Type: Article

References (34)

1. Albertazzi L, Gherardini L, Brondi M, Sulis Sato S, Bifone A, Pizzorusso T, et al. In vivo distribution and toxicity of PAMAM dendrimers in the Central Nervous System depend on their surface chemistry. Mol Pharm 2013;10(1):249-260
2. Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC. 1998. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. J Immunol 161:2552-2560
3. Babcock AA, Kuziel WA, Rivest S, Owens T. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23:7922-7930
4. Bardi G, Malvindi MA, Gherardini L, Costa M, Pompa PP, Cingolani R, et al. 2010. The biocompatibility of amino functionalized CdSe/ZnS quantum-dot-Doped SiO2 nanoparticles with primary neural cells and their gene carrying performance. Biomaterials 31:6555-6566
5. Brown RC, Morris AP, O'Neil RG. 2007. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 1130:17-30
6. Chen Y, Dalwadi G, Benson HA. 2004. Drug delivery across the bloodbrain barrier. Curr Drug Deliv 1:361-376
7. Cohen S. 1976. Cell mediated immunity and the inflammatory system. Hum Pathol 7:249-264
8. Daniel WA. 2003. Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 27:65-73
9. Dhanikula RS, Hammady T, Hildgen P. 2009. On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood-brain barrier model. J Pharm Sci 98:3748-3760
10. Duncan R, Izzo L. 2005. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215-2237
11. Gagliardi M, Bardi G, Bifone A. 2012. Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS. Ther Deliv 3:875-887
12. Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi X, et al. 2004. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: Hole formation and the relation to transport. Bioconjug Chem 15:774-782
13. Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, et al. 2006. Interaction of polycationic polymers with supported lipid bilayers and cells: Nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem 17:728-734
14. Huang D, Wujek J, Kidd G, He TT, Cardona A, Sasse ME, et al. 2005. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J 19:761-772
15. Kannan S, Dai H, Navath RS, Balakrishnan B, Jyoti A, Janisse J, et al. 2012. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med 4:130ra46
16. Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson K. A. 2010. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31:9511-9518
17. Li G, Simon MJ, Cancel LM, Shi ZD, Ji X, Tarabell JM, et al. 2010. Permeability of endothelial and astrocyte cocultures: In vitro bloodbrain barrier models for drug delivery studies. Ann Biomed Eng 38:2499-2511
18. Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, Cingolani R, et al. 2010. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 4:7481-7491
19. Martin H, Kinns H, Mitchell N, Astier Y, Madthil R, Howorka S. 2007. Nanoscale protein pores modified with PAMAM dendrimers. J Am Chem Soc 129:9640-9649
20. Meng F, Lowell CA. 1997. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J Exp Med 185:1661-1670
21. Mukherjee SP, Byrne HJ. 2012. Polyamidoamine dendrimer nanoparticle cytotoxicity, oxidative stress, caspase activation and inflammatory response: Experimental observation and numerical simulation. Nanomedicine 2012 May 23. [Epub ahead of print]
22. Mukherjee SP, Davoren M, Byrne HJ. 2010a. In vitro mammalian cytotoxicological study of PAMAM dendrimers-Towards quantitative structure activity relationships. Toxicol In Vitro 24:169-177
23. Mukherjee SP, Lyng FM, Garcia A, Davoren M, Byrne HJ. 2010b. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol Appl Pharmacol 248:259-268
24. Naka K. 2003. Effect of dendrimers on the crystallization of calcium carbonate in aqueous solution. Top Curr Chem 228:141-158
25. Pardridge WM. 2007. Blood-brain barrier delivery. Drug Discov Today 12:54-61
26. Pavan GM, Monteagudo S, Guerra J, Carrion B, Ocana V, Rodriguez-Lopez J, et al. 2012. Role of generation, architecture, pH and ionic strength on successful siRNA delivery and transfection by hybrid PPV-PAMAM dendrimers. Curr Med Chem 19 (29):4929-4941
27. Perez-Martinez FC, Guerra J, Posadas I, Cena V. 2011. Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharm Res 28:1843-1858
28. Perez-Martinez FC, Ocana AV, Perez-Carrion MD, Cena V. 2012. Dendrimers as vectors for genetic material delivery to the nervous system. Curr Med Chem 19(29):5101-5108
29. Posadas I, Guerra FJ, Cena V. 2010. Nonviral vectors for the delivery of small interfering RNAs to the CNS. Nanomedicine (Lond) 5:1219-1236
30. Poupot M, Griffe L, Marchand P, Maraval A, Rolland O, Martinet L, et al. 2006. Design of phosphorylated dendritic architectures to promote human monocyte activation. FASEB J 20:2339-2351
31. Prinz M, Priller J, Sisodia SS, Ransohoff RM. 2011. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 14:1227-1235
32. Ransohoff RM, Liu L, Cardona AE. 2007. Chemokines and chemokine receptors: Multipurpose players in neuroinflammation. Int Rev Neurobiol 82:187-204
33. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762-774
34. Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. 2008. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv 5:155-174